Factors associated with Medicaid patients' access to buprenorphine treatment
Saved in:
Baxter, J.D., ET AL., Factors associated with Medicaid patients' access to buprenorphine treatment. Journal of Substance Abuse Treatment, Vol. 41, no. 1 (2011), p. 88-96.
Ref.
181693
Location:
SIIS R.991 Archivo
Palabras clave:
Acceso, Buprenorfina, Características usuario, Drogas ilegales, Drogodependencias, Opiáceos, Programas de mantenimiento, Reducción de daños, Tratamiento, EE.UU.
Acceso, Buprenorfina, Características usuario, Drogas ilegales, Drogodependencias, Opiáceos, Programas de mantenimiento, Reducción de daños, Tratamiento, EE.UU.
Similar Items: Factors associated with Medicaid patients' access to buprenorphine treatment
- Illicit buprenorphine use, interest in and access to buprenorphine treatment among syringe exchange participants
- Association between trajectories of buprenorphine treatment and emergency department and in-patient utilization
- FACTORS ASSOCIATED WITH THE PRECRIBING OF BUPRENORPHINE OR METHADONE FOR TREATMENT OF OPIATE DEPENDENCE
- The impact of buprenorphine on treatment of opioid dependence in a Medicaid population: Recent service utilization trends in the use of buprenorphine and methadone
- Diversion of methadone and buprenorphine by patients in opioid substitution treatment in Sweden: Prevalence estimates and risk factors
- Integrating buprenorphine treatment into a public healthcare system: the San Francisco Department of Public Health's Office. Based Buprenorphine Pilot Program